biote

BTMDNasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$46.706 M

$1.30 -1.51%

Close of 23 Sept 2026

Revenue

$192.2M

#2295 by revenue

Earnings

$27.0M

#1769 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

1.7

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#18Fitlife BrandsFTLF$88.2M
#19Ispire TechnologyISPR$76.5M
#20bioteBTMD$46.7M
#21MannatechMTEX$14.8M
#22Natural Alternatives InternationalNAII$11.6M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of biote, worth $202.2K. Grants and option exercises are excluded.

Marc D. BeerExecutive Chairman$202.2K
131,950 shares at $1.53 on 10 Aug 2026 · filed 12 Aug 2026

What if biote were worth as much as…

Open the what-if tool →

Gold $29.8T

$830,755.10

Per share 639,042× higher

Bitcoin $1.69T

$47,153.90

Per share 36,272× higher

Nvidia $5.43T

$151,271.20

Per share 116,362× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for biote are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.